CADTH | Search

Current Filters

Showing 31 - 40 results of 3579

Xtandi First Line mCRPC - Details (Xtandi) (Last Updated: Jul 31, 2015)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indication

Brand Name:
Xtandi
Manufacturer:
Astellas Pharma Canada, Inc.
Submission Type:
Initial

Xalkori for Advanced NSCLC - Resubmission - Details (Xalkori) (Last Updated: Jun 17, 2013)

The manufacturer, Pfizer Canada Inc. has resubmitted to pCODR for the Crizotinib (Xalkori) Advanced NSCLC submission. Please see the Crizotinib (Xalkori) for Advanced NSCLC Details page for...

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indication

Brand Name:
Xalkori
Manufacturer:
Pfizer Canada Inc.
Submission Type:
Resubmission

Xalkori for Advanced Non-Small Cell Lung Cancer (Xalkori) (Last Updated: Oct 22, 2012)

The manufacturer, Pfizer Canada Inc. has resubmitted to pCODR for Crizotinib (Xalkori) Advanced NSCLC. Please see the Crizotinib (Xalkori) for Advanced NSCLC Resubmission Details page for more...

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indication

Brand Name:
Xalkori
Manufacturer:
Pfizer Canada Inc.
Submission Type:
Initial

Votrient for Soft Tissue Sarcoma (Votrient) (Last Updated: Dec 14, 2012)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indication

Brand Name:
Votrient
Manufacturer:
GlaxoSmithKline Inc.
Submission Type:
Initial

Votrient for metastatic renal cell carcinoma - Resubmission - Details (Votrient) (Last Updated: Sep 17, 2013)

The manufacturer, GlaxoSmithKline Inc. has resubmitted to pCODR for the Pazopanib Hydrochloride (Votrient) submission. Please see the Pazopanib hydrochloride (Votrient) for Metastatic Renal Cell...

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indication

Brand Name:
Votrient
Manufacturer:
GlaxoSmithKline Inc.
Submission Type:
Resubmission

Votrient for metastatic renal cell carcinoma - Details (Votrient) (Last Updated: Jan 20, 2012)

CLARIFICATION: The manufacturer, GlaxoSmithKline Inc. has resubmitted to pCODR for Pazopanib Hydrochloride (Votrient) submission. Please see the Pazopanib hydrochloride (Votrient) for Metastatic Renal...

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indication

Brand Name:
Votrient
Manufacturer:
GlaxoSmithKline Inc.
Submission Type:
Initial

Velcade for Multiple Myeloma - Details (Velcade) (Last Updated: Apr 11, 2013)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indication

Brand Name:
Velcade
Manufacturer:
Janssen
Submission Type:
Initial

Trisenox for Acute Promyelocytic Leukemia - Details (Trisenox) (Last Updated: Feb 18, 2014)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indication

Brand Name:
Trisenox
Manufacturer:
Lundbeck Canada Inc.
Submission Type:
Initial
Download results as CSV